D-0313-2025 Class II Terminated
FDA drug recall D-0313-2025 was initiated by ASEGUA THERAPEUTICS LLC on Mar 7, 2025 and is designated Class II. Reason for recall: Defective Container: blister packs not properly sealed resulting in tablets being loose in the carton. The recall status is terminated (terminated Sep 29, 2026). Affected quantity: 18,541 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 16, 2025
- Initiation Date
- Mar 7, 2025
- Termination Date
- Sep 29, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 18,541 cartons.
Product description
Sofosbuvir and Velpatasvir, 400 mg/100 mg tablets, 28 tablets: 2x14 blister cards, Rx Only, Manufactured for: Asegua Therapeutics LLC an affiliate of Gilead Sciences, Inc., Foster City, CA 94404, Made in Ireland, NDC# 72626-2701-1
Reason for recall
Defective Container: blister packs not properly sealed resulting in tablets being loose in the carton.
Distribution pattern
US Nationwide
Code information
Lot# 24ASV002UA, Exp Date: 6/30/2028
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0313-2025
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026